The results indicate that the mRNA expression levels of CIRBP and INPP5K are significantly downregulated and associated with the clinical outcomes of patients with cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), uterine corpus endometrial carcinoma (UCEC) and ovarian serous cystadenocarcinoma (OV). This evidence concerns the gene INPP5K and cervical squamous cell carcinoma.